Nexplanon Implant
NDC Package 78206-145-01
Package Information
Nexplanon (etonogestrel) implants is a medication a small, thin plastic rod that is inserted under the skin to prevent pregnancy. This formulation utilizes a implant delivery system. Marketed by Organon Llc, this product is identified by NDC 78206-145 and is authorized under FDA application NDA021529.
Identification & Billing
- RxCUI: 1111011 - Nexplanon 68 MG Subdermal Drug Implant
- RxCUI: 1111011 - etonogestrel 68 MG Drug Implant [Nexplanon]
- RxCUI: 1111011 - Nexplanon 68 MG Drug Implant
- RxCUI: 389221 - etonogestrel 68 MG Subdermal Drug Implant
- RxCUI: 389221 - etonogestrel 68 MG Drug Implant
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 78206 - Organon Llc
- 78206-145 - Nexplanon
- 78206-145-01 - 1 BLISTER PACK in 1 CARTON / 1 IMPLANT in 1 BLISTER PACK
- 78206-145 - Nexplanon
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 78206-145-01 identifies a specific commercial package of 1 blister pack in 1 carton / 1 implant in 1 blister pack of Nexplanon, a human prescription drug labeled by Organon Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This implant is formulated for subcutaneous use and contains etonogestrel as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Organon Llc on June 01, 2021. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This product is a small, thin plastic rod that is inserted under the skin to prevent pregnancy. The rod slowly releases etonogestrel into the body over a 3-year period. Etonogestrel is similar to a natural hormone made in your body. It works mainly by preventing the release of an egg (ovulation) during your menstrual cycle. It also makes vaginal fluid thicker to help prevent sperm from reaching an egg (fertilization) and changes the lining of the uterus (womb) to prevent attachment of a fertilized egg. This product does not contain any estrogen. This medication may not work as well in women who are very overweight or those taking certain drugs. (See also Drug Interactions section.) Discuss your birth control options with your doctor. Using this medication does not protect you or your partner against sexually transmitted diseases (such as HIV, gonorrhea, chlamydia).
How is this Organon Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 78206014501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.